Alligator Bioscience AB (publ) (STO:ATORX)
4.431
+0.231 (5.50%)
Aug 22, 2025, 5:29 PM CET
Alligator Bioscience AB Revenue
Alligator Bioscience AB had revenue of 89.00K SEK in the quarter ending June 30, 2025, a decrease of -98.79%. This brings the company's revenue in the last twelve months to 43.75M, down -4.80% year-over-year. In the year 2024, Alligator Bioscience AB had annual revenue of 57.72M, down -2.58%.
Revenue (ttm)
43.75M
Revenue Growth
-4.80%
P/S Ratio
3.53
Revenue / Employee
2.92M
Employees
45
Market Cap
154.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 57.72M | -1.53M | -2.58% |
Dec 31, 2023 | 59.25M | 23.25M | 64.58% |
Dec 31, 2022 | 36.00M | 22.67M | 170.14% |
Dec 31, 2021 | 13.33M | 7.81M | 141.65% |
Dec 31, 2020 | 5.52M | 1.16M | 26.55% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.52B |
AddLife AB | 10.44B |